Contemporary Status of Percutaneous Ablation for the Small Renal Mass

Benjamin J. Shin, Jeffrey Forris Beecham Chick, S. William Stavropoulos

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations. Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses.

Original languageEnglish (US)
Article number23
Pages (from-to)1-9
Number of pages9
JournalCurrent urology reports
Volume17
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Kidney
Cryosurgery
Nephrons
Therapeutics
Microwaves
Nephrectomy
Renal Cell Carcinoma
Neoplasms
Recurrence
Population

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Shin, Benjamin J. ; Chick, Jeffrey Forris Beecham ; Stavropoulos, S. William. / Contemporary Status of Percutaneous Ablation for the Small Renal Mass. In: Current urology reports. 2016 ; Vol. 17, No. 3. pp. 1-9.
@article{d2c3da9785e747f2b178b3755062df9c,
title = "Contemporary Status of Percutaneous Ablation for the Small Renal Mass",
abstract = "Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations. Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses.",
author = "Shin, {Benjamin J.} and Chick, {Jeffrey Forris Beecham} and Stavropoulos, {S. William}",
year = "2016",
month = "3",
day = "1",
doi = "10.1007/s11934-016-0581-7",
language = "English (US)",
volume = "17",
pages = "1--9",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "3",

}

Contemporary Status of Percutaneous Ablation for the Small Renal Mass. / Shin, Benjamin J.; Chick, Jeffrey Forris Beecham; Stavropoulos, S. William.

In: Current urology reports, Vol. 17, No. 3, 23, 01.03.2016, p. 1-9.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Contemporary Status of Percutaneous Ablation for the Small Renal Mass

AU - Shin, Benjamin J.

AU - Chick, Jeffrey Forris Beecham

AU - Stavropoulos, S. William

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations. Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses.

AB - Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations. Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses.

UR - http://www.scopus.com/inward/record.url?scp=84958167855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958167855&partnerID=8YFLogxK

U2 - 10.1007/s11934-016-0581-7

DO - 10.1007/s11934-016-0581-7

M3 - Review article

C2 - 26874535

AN - SCOPUS:84958167855

VL - 17

SP - 1

EP - 9

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 3

M1 - 23

ER -